Last reviewed · How we verify
TJ101
TJ101 is a small molecule that targets the [insert target here, if known].
TJ101 is a small molecule that targets the [insert target here, if known]. Used for Phase 3 for [insert indication here, if known].
At a glance
| Generic name | TJ101 |
|---|---|
| Sponsor | TJ Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
TJ101 works by binding to [insert target here, if known] and [insert mechanism here, if known].
Approved indications
- Phase 3 for [insert indication here, if known]
Common side effects
- Unknown
Key clinical trials
- A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China (PHASE1)
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors (PHASE1)
- A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |